Graeven U - Search Results

1

In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression.

Graeven U, Herlyn M. Graeven U, et al. J Immunother (1991). 1992 Oct;12(3):199-202. doi: 10.1097/00002371-199210000-00012. J Immunother (1991). 1992. PMID: 1445812

2

Stable transfection of human malignant melanoma cells with basic fibroblast growth factor antisense cDNA.

Graeven U, Rodeck U, Weinmann R, Herlyn M. Graeven U, et al. Ann N Y Acad Sci. 1992 Oct 28;660:293-4. doi: 10.1111/j.1749-6632.1992.tb21090.x. Ann N Y Acad Sci. 1992. PMID: 1340139 No abstract available.

3

Characterization of tenascin secreted by human melanoma cells.

Herlyn M, Graeven U, Speicher D, Sela BA, Bennicelli JL, Kath R, Guerry D 4th. Herlyn M, et al. Among authors: graeven u. Cancer Res. 1991 Sep 15;51(18):4853-8. Cancer Res. 1991. PMID: 1716515

4

Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.

Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C, Kari C. Rodeck U, et al. Among authors: graeven u. Cancer Res. 1994 Jan 15;54(2):575-81. Cancer Res. 1994. PMID: 8275496

5

Expression patterns of placenta growth factor in human melanocytic cell lines.

Graeven U, Rodeck U, Karpinski S, Jost M, Andre N, Schmiegel W. Graeven U, et al. J Invest Dermatol. 2000 Jul;115(1):118-23. doi: 10.1046/j.1523-1747.2000.00022.x. J Invest Dermatol. 2000. PMID: 10886518 Free article.

6

Negative regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells via a retinoic acid response element.

Kralli A, Ge R, Graeven U, Ricciardi RP, Weinmann R. Kralli A, et al. Among authors: graeven u. J Virol. 1992 Dec;66(12):6979-88. doi: 10.1128/JVI.66.12.6979-6988.1992. J Virol. 1992. PMID: 1433503 Free PMC article.

7

Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR.

Graeven U, Fiedler W, Karpinski S, Ergün S, Kilic N, Rodeck U, Schmiegel W, Hossfeld DK. Graeven U, et al. J Cancer Res Clin Oncol. 1999 Nov;125(11):621-9. doi: 10.1007/s004320050325. J Cancer Res Clin Oncol. 1999. PMID: 10541969

8

Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.

Graeven U, Rodeck U, Karpinski S, Jost M, Philippou S, Schmiegel W. Graeven U, et al. Cancer Res. 2001 Oct 1;61(19):7282-90. Cancer Res. 2001. PMID: 11585767

9

Transforming region of 243R E1A contains two overlapping but distinct transactivation domains.

Sang N, Claudio PP, Fu Y, Horikoshi N, Graeven U, Weinmann R, Giordano A. Sang N, et al. Among authors: graeven u. DNA Cell Biol. 1997 Nov;16(11):1321-33. doi: 10.1089/dna.1997.16.1321. DNA Cell Biol. 1997. PMID: 9407004

10

Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma.

Graeven U, Andre N, Achilles E, Zornig C, Schmiegel W. Graeven U, et al. J Cancer Res Clin Oncol. 1999 Oct;125(10):577-81. doi: 10.1007/s004320050319. J Cancer Res Clin Oncol. 1999. PMID: 10473871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters